Article

The frequency and inter-relationship of PD-L1 expression and tumour mutational burden across multiple types of advanced solid tumours in China

2020-04-10

Abstract excerpt

<h4>Background: </h4> PD-L1 expression and tumour mutational burden (TMB) have been demonstrated to be associated with the responses of multiple tumours to ICI therapy. Their prevalence and correlations in various types of advanced solid tumours from Chinese patients warrant further study. <h4>Methods: </h4>: PD-L1 expression, TMB, PD-1 + Tils infiltration and the relationships among them were assessed in 6,668 ad...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 23b3e32b-e72f-5b29-904c-8041f01c13ea
DOI: 10.21203/rs.3.rs-22028/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The frequency and inter-relationship of PD-L1 expression and tumour mutational burden across multiple types of advanced solid tumours in ChinaDOI 10.21203/rs.3.rs-22028/v1Read

Mutation mapping of PD-L1 expression in advanced non-small cell lung cancer: A real-world retrospective cohort studySemantic proximity Read

High tumor mutational burden predicts survival and responses to ICI immunotherapy in a cancer-dependent mannerSemantic proximity Read

PD-L1 expression and its correlation with tumor biomarkers in Chinese urothelial bladder cancer.Semantic proximity Read

Clinicopathological and molecular characteristics associated with PD-L1 expression in non-small cell lung cancer: a large-scale, multi-center, real-world study in China.Semantic proximity Read

In-Depth Genomic Characterization of Programmed Cell Death Ligand 1 (PD-L1) Expression in Chinese Lung Adenocarcinoma PatientsSemantic proximity Read

Who Will Benefit Most From PD-L1 Detection and Immunotherapy in Non-small Cell Lung Cancer?Semantic proximity Read

High tumor mutational burden predicts favorable response to anti-PD-(L)1 therapy in patients with solid tumor: a real-world pan-tumor analysis.Semantic proximity Read

PD-L1 expression and tumor mutational burden are independent biomarkers in most cancersSemantic proximity Read

Comprehensive Genomic Profiling of Rare Tumors in China: Routes to Immunotherapy.Semantic proximity Read

Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapySemantic proximity Read

Comprehensive analysis of potential immunotherapy genomic biomarkers in 1,000 Chinese patients with cancerSemantic proximity Read

The current status and future of PD-L1 in liver cancerSemantic proximity Read